Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.JCI Insight|April 20, 2018
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myelomaAlfred L Garfall, Edward A Stadtmauer, Wei-Ting Hwang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cellsAndrew R Haas, Ryan J Golden, Leslie A Litzky, et al.Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.Nature Medicine|April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.Nature Medicine|July 21, 2015
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myelomaAaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, et al.The Journal of Clinical Investigation|August 16, 2021
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemiaWeimin Kong, Alexander Dimitri, Wenliang Wang, et al.Nature|June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cellsJoseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.Science (New York, N.Y.)|July 17, 2020
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsDivij Mathew, Josephine R Giles, Amy E Baxter, et al.Pageof 11